NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Evaluation Expert Panel on Detection · JAMA · 2001 · 26K citations

Medicine, Cardiology, Otolaryngology +10

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.9K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Christopher P. Cannon, Michael A. Blazing, Robert P. Giugliano et al. · New England Journal of Medicine · 2015 · 4.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

M. H. Frick, Olli Elo, Kauko Haapa et al. · New England Journal of Medicine · 1987 · 3.9K citations

Medicine, Cardiology, Pharmacotherapy +17

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17